Clinical Trials · NCT01787916
52 Week Trial of Liraglutide in Type 1 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- CHU de Quebec-Universite Laval
- Enrollment
- 15
- Start date
- Apr 2013
- Locations
- 1 site, Canada
- Primary endpoint
- Assessment of Changes in Glycemic Control by HbA1c.